Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05320692
What this trial is testing

TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 423
Post-approval studies (Phase 4)UnknownNCT06590844
What this trial is testing

"cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma
Anhui Provincial Hospital 37
Testing effectiveness (Phase 2)UnknownNCT03971201
What this trial is testing

Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion

Who this might be right for
Hepatocellular Cancer
White Plains Hospital 200
Testing effectiveness (Phase 2)UnknownNCT00282100
What this trial is testing

Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma

Who this might be right for
Liver Cancer
Tan Tock Seng Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02509507
What this trial is testing

Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611

Who this might be right for
Hepatocellular CarcinomaLiver MetastasesCutaneous or Subcutaneous Lymph Node+1 more
Amgen 127
Testing effectiveness (Phase 2)Study completedNCT05104567
What this trial is testing

SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

Who this might be right for
Oesophageal Squamous Cell CarcinomaGastric CancerHepatocellular Carcinoma+2 more
Sanofi 138
Testing effectiveness (Phase 2)Active Not RecruitingNCT03654131
What this trial is testing

Microwave Ablation Versus Stereotactic Body Radiotherapy for Colorectal Liver Metastases in Oligometastatic Disease: a Prospective, Randomised, Phase 2 Trial

Who this might be right for
Colorectal CarcinomaLiver Metastases
Rigshospitalet, Denmark 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07412054
What this trial is testing

Lenvatinib and Pembrolizumab With or Without BCAA in Unresectable HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
Fudan University 234
Not applicableStudy completedNCT07034495
What this trial is testing

Laparotomy, Laparoscopy, da Vinci System

Who this might be right for
Stomach NeoplasmsPancreatic NeoplasmsLiver Neoplasms+5 more
National Chung Hsing University 486
Testing effectiveness (Phase 2)Study completedNCT00107536
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 26
Large-scale testing (Phase 3)Study completedNCT04039607
What this trial is testing

Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Bristol-Myers Squibb 732
Testing effectiveness (Phase 2)Study completedNCT03086564
What this trial is testing

A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment (BTRHBVAPHCLCDCCTCHBVHCCT)

Who this might be right for
Hepatocellular Carcinoma
Yuehua Huang 70
Testing effectiveness (Phase 2)WithdrawnNCT01953406
What this trial is testing

The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLung Metastasis
Seoul National University Hospital
Post-approval studies (Phase 4)UnknownNCT02631499
What this trial is testing

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

Who this might be right for
Carcinoma, HepatocellularNeoplastic Cells, Circulating
Fudan University 256
Post-approval studies (Phase 4)Ended earlyNCT01760616
What this trial is testing

Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy

Who this might be right for
Hepatic Carcinoma
Qidong Gaitianli Medicines Co., Ltd 790
Testing effectiveness (Phase 2)Study completedNCT01714609
What this trial is testing

The Effect of Sorafenib on Portal Pressure

Who this might be right for
Clinically Significant Portal Hypertension
Yale University 10
Testing effectiveness (Phase 2)UnknownNCT04224636
What this trial is testing

Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ludwig-Maximilians - University of Munich 106
Testing effectiveness (Phase 2)Study completedNCT01192971
What this trial is testing

Apatinib in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 121
Not applicableStudy completedNCT01798134
What this trial is testing

Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 25
Not applicableWithdrawnNCT01710293
What this trial is testing

Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis

Who this might be right for
Lung CancerBladder CancerColorectal Cancer+2 more
VA Office of Research and Development
Next Page